insights_auto
Why is SABS up 8,47%?
Dive Deeperchevron_right
SABS:NASDAQ
SAB Biotherapeutics Inc
3,20 US$
arrow_upward
+8,47%(+0,25) 1D
3,20 US$
0,00% (0,00)
bedtimeAfter hours
Closed: 18 ნოე, 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SABS...
Open
2,96 US$
High
3,32 US$
Low
2,95 US$
Mkt. cap
288,28 მლნ.
Avg. vol.
682,51 ათ.
Volume
137,00
52-wk high
5,15 US$
52-wk low
2,44 US$
EPS
-0,93 US$
Beta
0,67
Shares outstanding
90,09 მლნ.
No. of employees
86
Open
2,96 US$
High
3,32 US$
Low
2,95 US$
Mkt. cap
288,28 მლნ.
Avg. vol.
682,51 ათ.
Volume
137,00
52-wk high
5,15 US$
52-wk low
2,44 US$
EPS
-0,93 US$
Beta
0,67
Shares outstanding
90,09 მლნ.
No. of employees
86
News stories
From web sources and news partners
Investing.com
·
2 დღის წინ
SAB Biotherapeutics at UBS conference: late-stage diabetes bet
About SAB Biotherapeutics Inc
CEO-
Employees86
Founded2014
Headquartersმაიამი-ბიჩი, ფლორიდა, ამერიკის შეერთებული შტატები
SectorHealth Care
Industry-
Websitesab.bio